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Abstract 
 
This study investigated the development of a novel approach to surface characterisation of drug 
polymorphism and the extension of the capabilities of this method to perform ‘real time’ in situ 
measurements. This was achieved using diffuse reflectance visible spectroscopy (DRV 
spectroscopy) and dye deposition, using the pH sensitive dye, thymol blue (TB). Two 
polymorphs, SFN-ȕ and SFN-Ȗ, of the drug substance sulfanilamide (SFN) were examined. The 
interaction of adsorbed dye with polymorphs showed different behavior, and thus reported 
different DRV spectra.  Consideration of the acid/base properties of the morphological forms 
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of the drug molecule provided a rationalization of the mechanism of differential coloration by 
indicator dyes.  The kinetics of the polymorphic transformation of sulfanilamide polymorphs 
was monitored using treatment with TB dye and DRV spectroscopy. The thermally-induced 
transformation fitted a first-order solid-state kinetic model (R2 = 0.992), giving a rate constant 
of 2.43 x 10-2 s-1.  
 
 
 
Keywords: Polymorphic transformation, Sulfanilamide, Diffuse reflectance visible 
spectroscopy, Powder X-ray diffraction, Differential scanning 
Calorimetry. 
 
 
1. Introduction 
 Polymorphic transformations can have a significant influence on the processing and 
storage of crystalline powders. Change in crystalline structure affects the therapeutic 
effectiveness and stability of drug products, therefore the ability to monitor the effect of process 
stages on drug polymorphic transformation is crucial in drug manufacture [1]. The 
transformation from one polymorphic form to another can be thermally, mechanically or 
moisture-induced.  
 
Solid-state phase (polymorphic) transformations are generally based on overlapping 
mechanisms of nucleation, growth and impingement [2,3].  Solid-state kinetic evaluation 
typically involves modelling the fraction transformed as a function of time.  
Equation 1 represents a generic integral rate equation for solid-state kinetics: 
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                                                       (1) 
 
Where g is a function of the extent of reaction,  is the fraction of phase transformed or extent 
of growth of new phase, k is the rate constant, and t is time. The kinetics of the phase 
transformation is heterogeneous in nature, which suggests that several factors affect the kinetics 
of transformation including activation energy of nucleation and growth, difference in the crystal 
imperfections, particle size and particle morphology, and variation in growth rate along 
crystallographic axes. These factors contribute to the development of different models used in 
the characterisation of the kinetics of solid-state phase transformation resulting in acceleratory, 
deceleratory, linear or sigmoidal shapes for their respective isothermal α-time curves [3,4] . 
 
A variety of techniques have been employed to characterize the kinetics of polymorphic 
transformation in situ. Examples include near infrared spectroscopy (NIR) [5,6], vibrational 
spectroscopy [7,8],  powder X-ray diffraction [9] and temperature-controlled simultaneous 
small/wide angle X-ray scattering [10].  Previous reports also include the study of the 
thermodynamics of the conversion of sulfanilamide (SFN) polymorphs by energy dispersive 
XRD [11].  Monitoring processes, especially by in situ methods including DRV spectroscopy, 
offer a better understanding of the intrinsic properties of systems thus improving process  
control [12] .  
 
This study reports on a novel ‘real time’ method for monitoring thermally induced conversion of 
polymorphs using DRV spectroscopy and kinetic evaluation of the generated data. Polymorphs 
of sulfanilamide (SFN) were examined. The two polymorphs (SFN-ȕ and SFN-Ȗ) studied are 
enantiotropically related and the conversion of SFN-ȕ to SFN-Ȗ can be induced at elevated 
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temperatures. Although other reports on the analysis of polymorphs include the use of 
near infrared spectroscopy (NIR) [5,6] and vibrational spectroscopy [7,8], we have used 
DVR spectroscopy as the technique of choice for this study. We have experience in the 
use DRV spectroscopy for the differentiation of crystalline and amorphous forms of 
carbohydrate pharmaceutical excipients and in this study we explored the extension of 
the sensitivity, simplicity of operation and ease of data analysis of this technique to 
more complex active pharmaceutical ingredients. Furthermore, initial attempts at 
monitoring polymorphic interconversion using Raman spectroscopy proved ineffective. 
 
 
 
 
2. Experimental  
2.1 Chemicals and preparation 
SFN-ȕ was prepared by recrystallization in water. Commercial sulfanilamide, >99.0 % , from 
Sigma Aldrich (Dorset, England) was dissolved in hot water (at 100 ºC) and left to cool to 
ambient temperature (23.5 ºC).  SFN-ȕ was filtered under suction and dried over calcium 
chloride in a desiccator.  SFN-Ȗ was obtained from recrystallized SFN-ȕ that was heated at 140 
ºC for 2 h. All polymorphs were stored in a desiccator over calcium chloride (0 % RH) prior to 
analysis to eliminate moisture-induced transformations. 
 
2.2 Instrumentation  
Philips PW1729 Powder x-ray diffractometer experiments were carried out with a PW1050 
goniometer (Lelyweg, Netherlands). Differential scanning calorimetry (DSC) was performed 
on a Mettler Toledo FP85 DSC system (Greifense, Sweden). Raman spectroscopy was 
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carried out on a Thermo-Nicolet NXR FT-Raman 9610 spectrometer (Wisconsin, USA).  
DRV spectroscopy was performed on a Hewlett-Packard 8453 photodiode Array UV-Vis 
Spectrophotometer (California, USA) equipped with a Labsphere RSA-HP-8453 diffuse 
reflectance accessory (Illinois, USA). Hot-stage microscopy was preformed using a Leica 
optical microscope (Wetzlar, Germany) fitted with a Mettler FP52 hot stage apparatus 
(Greifense, Switzerland). 
Single crystal data for all polymorphs obtained from the Cambridge Crystal Structural Database 
(CCSD Codes, SFN ȕ SULAMD0γ [1γ] and SFN Ȗ  SULAMD02 [14] ) were imputed into the 
Reflex module of Materials Studio 5.0 software program from Accelrys (San Diego, USA ) to 
obtain simulated powder x-ray data and Miller indices for all reflections. 
A full description of the DRV spectroscopy methodology can be found in a previous report by 
Major, Wicks, Alexander and Mitchell [15]. 
3. Results and discussion 
 
3.1 Preparation and characterization of SFN-ȕ and SFN- Ȗ polymorphs and SFN-ȕ-TB 
 and SFN-Ȗ-TB  
 
In this study two polymorphs of sulfanilamide (SFN) were examined. The two polymorphs, 
SFN-ȕ and SFN-Ȗ studied are enantiotropically related and the conversion of SFN-ȕ to SFN-Ȗ 
can be induced at elevated temperatures, making them good candidates for ‘real time’ 
polymorphic interconversion. 
The two polymorphs of SFN (ȕ and Ȗ forms) were prepared and analyzed using x-ray diffraction, 
and scanning calorimetry. Four polymorphs of SFN have been recorded, but ȕ and Ȗ are more 
accessible. The ȕ form is the most stable form under ambient conditions. 
The experimental and simulated powder X-ray diffraction (PXRD) patterns for SFN-ȕ and SFN- 
6 
Ȗ polymorphs are shown in Fig. 1. The PXRD patterns are different and show defined and sharp 
peaks which are indicative of their crystalline nature. Experimental 2theta angles agree within ± 
0.20º of simulated data confirming polymorphic purity; however, peak intensities vary 
significantly as a result of preferred orientation of several atomic planes to incident X-ray beam.  
 
Fig 1  
 
The thermal behaviors of SFN polymorphs were also analysed.  DSC-thermograms show a 
single endothermic event for SFN- Ȗ (Tf =162.3±0.3 ºC and ΔHf =146.0±1.0 Jg–1) attributed to 
melting. However, three endothermic transitions Tf =128.3 ±1.3 ºC, ΔHf =6.9±3.0 Jg–1; Tf 
=156.0±1.3 ºC, ΔHf =1.33±0.5 Jg–1 ; and Tf =162.3±0.3 ºC, ΔHf =121.0±3.5 Jg–1 , were observed 
for SFN-ȕ attributable to incomplete ȕ → Ȗ transformation, melting residual SFN-ȕ and melting 
of SFN-Ȗ respectively.  
 
Dye deposition was achieved using drop-wise addition of 1 mL of methanolic dye (200 mg/L) 
solution of thymol blue (TB) directly onto 2 g of solid carefully homogenized using a spatula 
and dried. The typical amount of dye adsorbed per gram of solid was 0.1 mg, which corresponds 
to the limit of detection of adsorbed dye by the DRV instrument for most of the investigated 
polymorphic systems. Three separate sample preparations and DRV spectroscopic 
measurements were conducted for each polymorph. SFN-ȕ was always air-dried as oven-drying 
sometimes introduced SFN-Ȗ impurity. For SFN-Ȗ, dye deposition was achieved by heating dye 
treated SFN-ȕ to a temperature of 1β5 ºC for γ0 min. This heat-induced transformation method 
is suitable for SFN-Ȗ, because it is prone to solvent-induced polymorphic transformation to 
SFN-ȕ. 
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The SFN-ȕ-TB and SFN-Ȗ-TB were characterized by PXRD and DSC to confirm polymorphic 
form and also to ensure that crystalline integrity is maintained after dye treatment.  The 
samples were screened using sieves to determine particle distribution, whereby the majority had 
particle size values greater than 450 ȝm. 
PXRD patterns for SFN-ȕ treated with TB were compared to the untreated polymorph. Peaks at 
2theta values of 10.55, 14.43, 20.57, 21.24 and 22.72 agreed within ± 0.20° of untreated data. 
DSC thermograms of SFN-ȕ-TB samples were also analysed. Dye treated samples indicated 
only two events , i.e., the ȕ → Ȗ transformation (Tf =1βλ.0±0.5ºC and ΔHf =9.6±1.0 Jg–1) and the 
melting of SFN- ȕ (Tf =16β.4±0.5ºC and ΔHf =143± 1.0 Jg–1).  
 
PXRD patterns for SFN-Ȗ treated with TB were likewise compared with the untreated 
polymorph. Peaks at 2theta values of 11.55, 13.43, 19.69, 24.25 and 29.36 agreed within ± 0.20° 
of untreated data. DSC thermograms of SFN-Ȗ dye treated with TB were again compared to the 
untreated polymorph. A single endothermic melting was observed for all samples. The onset 
temperature (Tf) and enthalpy of fusion (ΔHf values) were Tf =16β.6±0.5ºC and ΔHf =144.0±1.0 
Jg–1 for SFN-Ȗ-TB.   
 
 
3.2 Isothermal kinetic studies of SFN-ȕ transformation monitoring by DRV 
 
TB is a pH sensitive indicator normally used in solution. It contains two ionisable 
groups, i.e., a sulphonic acid group with a pKa of 1.6 and a phenolic group with a pKa of 
8.8.  Solution TB can exist as either a neutral species with a Ȝmax of 547 nm, a mono 
anionic form with a Ȝmax of 434, or as a di-anionic form with a Ȝmax of 598.  These forms 
of TB are clearly distinguishable by ultraviolet spectroscopy. SFN possesses two 
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ionisable functional groups, i.e., the basic phenyl amine group -NH2 (pKa 1.85±0.10) and 
sulfonamide –SONH2 group which acts as a weak acid (pKa 10.10±0.10), which can play a 
dominant role in dye deprotonation. The amine group is a stronger base than the sulfonamide 
group, so the deprotonation of dye molecules is greatly influenced by the surface accessibility of 
–NH2. The packing motif for both polymorphs may provide insight into the higher basicity of 
SFN-Ȗ. The DRV spectra of the polymorphs of SFN treated with thymol blue (TB) indicator are 
shown in Fig. 2. SFN-Ȗ-TB absorbs at Ȝmax 454 nm and 604 nm which are indicatives of the 
yellow mono-deprotonated and blue di-deprotonated species of the dye, respectively. Yellow 
SFN-ȕ-TB absorbs at 454 nm only, suggesting adsorbed mono-anionic TB. Values recorded are 
red shifted to solution values. It appears the deprotonation of adsorbed dye molecules is more 
extensive for SFN-Ȗ compared to SFN-ȕ i.e., the proportion of adsorbed TB2- is greater for 
SFN-Ȗ. Suggesting that SFN-Ȗ has a higher content of surface basic sites. Details of known 
solution characteristics of TB are presented in Table 1. pKa values reported in Table 1 were 
obtained using the ACD/I-Lab Web service and agree with reported literature values at 25 oC.  
 
Table 1. 
 
To establish a relationship between DRV spectroscopic response and mole fraction of 
polymorph transformed, calibration samples were prepared. Six calibration reference samples 
were prepared in the ratios: 0.0:1.0, 0.2:0.8, 0.4:0.6, 0.6:0.4, 0.8:0.2 and 1.0:0.0 of SFN-Ȗ-TB to 
SFN-ȕ-TB. These sample mixtures were homogenized by shaking in a stoppered bottle. DRV 
data were collected for the calibration standards and raw DRV spectroscopy data were treated 
by a smoothing algorithm. Spectral data were analysed in the range of 400 -750 nm and the data 
collection time was 5s.  
Untreated SFN-ȕ was used as a blank reference for DRV measurements. The DRV spectra for 
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the calibration reference samples are shown in Fig.2. Two overlapping bands occur at 454 and 
604 nm and with increasing amounts of SFN-Ȗ-TB, the height of the 604 nm band increases.   
 
Figure 2 
 
The calibration plot (inset Fig.2) is based on the ratio of peak heights (i.e., F(r)604nm/454nm) versus 
fractional amounts of dye treated SFN-Ȗ-TB. As the peaks were not baseline resolved, the bands 
were deconvoluted using the Gaussian curve fitting algorithm before a ratio of peak heights was 
determined. The plot reveals a regular relationship between the peak height ratio and fractional 
amounts of SFN-Ȗ-TB. This is analogous to the calibration plot of the ratio of peak heights 
versus pH for TB in solution.  The data in Fig. 2 suggest that DRV spectra for the calibration 
samples containing dye treated SFN polymorphs allows for differentiation between the two 
polymorphic forms, and therefore, calculation of the amount of SFN-Ȗ-TB converted to 
SFN-ȕ-TB.  It is, of course, possible to calculate from the first-order kinetic half-life, the 
amount of starting materials converted to morphed product and it is therefore possible to 
quantitatively differentiate and follow the interconversion of these two forms in ‘real time’. 
 
For ‘real time’ kinetic analysis, eight thin-walled glass vials were each loaded with 400mg of 
SFN-ȕ-TB. The vials were incubated in an oil bath equilibrated at 128 ⁰C at time points of t= 
7.5, 10, 30, 60, 90, 180, 240 and 360 s, upon which the samples were removed and immediately 
analysed by DRV spectroscopy. 
At the reaction extremity of t=360s, the sample was analysed using DSC to ensure complete 
transformation. DSC data of samples at t=360s compared well with the 1.0:0.0 ; SFN-Ȗ-TB: 
SFN-ȕ-TB calibration reference sample. 
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The DRV spectra (showing two main bands at 454 nm and 604 nm), collected as the 
transformation proceeded at 125±0.5 ºC, are shown in Fig. 3.  
 
Figure 3 
 
 
The ȕ → Ȗ transformation can be readily followed by the emergence and subsequent increase in 
the reflectance at 604 nm. The transformation seems to be complete at t=180s as the increase in 
the height of 604 nm band after this time point is not significant. The spectra were deconvoluted 
using the Gaussian curve fitting algorithm and peak ratios (F(r)604nm/454nm ) were calculated as a 
fraction converted (α) for each time point using the calibration plot earlier constructed.  
Data were plotted as the fraction of SFN-ȕ transformed (α/αmax) versus time (Fig. 4) , showing a 
deceleratory transformation curve that flattens at t=180 s. 
Experimental kinetic data within the range of αt=7.5 and αt=180(sec) were fitted to sixteen solid-state 
kinetics models by linear regression analysis. Of the models tried, the first-order kinetic model 
(Fig. 4) fitted best with a non-negative slope of k = 2.43 x 10-2 s-1 by analytical and graphical 
inspection.  
 
Fig. 4 
 
Analysis of the kinetics of a polymorphic transformation by more than one kinetic model is 
common, but in this case, only the first-order kinetic model described the transformation with 
favorable intercepts and R2 value. First-order transformation suggests that the kinetics was 
entirely nucleation-controlled and each SFN-ȕ crystallite within the sample form only a single 
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SFN-Ȗ nucleus that grew at a constant rate to transform the entire crystal and hence the entire 
sample. This finding is supported by the hot-stage microscopic observation of ȕ to Ȗ 
polymorphic transformation in a single crystal of SFN at 129 ºC, in which the observation 
showed the SFN-Ȗ initiating at a single nucleation site and then growing as a single crystal 
within the SFN-ȕ crystal [11].  Study of the transformation of SFN-ȕ to SFN-Ȗ in situ using 
EXRD also by Sheridan et al. suggested that kinetics is dominated by nucleation but not entirely 
nucleation controlled[11].  Particle size distribution, reaction temperature and the spectrum 
collection time employed herein could explain the differences in the transformation mechanism 
compared with that reported by Sheridan et al. 
 
 
4. Conclusions 
This study investigated the development of a novel approach to surface characterisation of drug 
polymorphism and the extension of the capabilities of this method to perform ‘real time’ in situ 
measurements of pharmaceutical active ingredients.  The kinetics of the polymorphic 
transformation of SFN polymorphs was monitored using TB dye and DRV spectroscopy. The 
thermally-induced transformation fitted a first-order solid-state kinetic model (R2 = 0.992), 
giving a rate constant of 2.43 x 10-2 s-1. This technique could be used for in situ measurement to 
allow monitoring of drug polymorphic inter-conversion and would be ideal for the study of 
rapid phase transformation, as in this study were the morphological transformation was 
complete in about 180 s. 
We intend to examine the effect of excipients on the UV absorption and quantitative 
differentiation of morphological form of active pharmaceuticals. We expect that, given the 
opportunity to avoid overlapping wavelengths from the excipients, we should be able to extend 
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this research to include the study of morphological change of drugs in the presence of 
excipients. 
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Table 1  Details of Thymol blue (TB) used in this study 
Indicator pKa Colour and λmaxb of ionisation 
species in solution 
Thymol blue (TB) 1.6a (Sulphonic acid) Red,    TBH2,        547 nm 
Yellow,  TBH- ,       434 nm 
Blue,    TB2- ,         598 nm 
 8.8±0.1 (Phenolic group) 
   
a  pKa values were obtained using the ACD/I-Lab Web service and were experimentally verified.  
b Colour and λmax of the corresponding ionisation species were experimentally determined in 
buffer indicator solutions at 25 ºC covering a range of 1-10 pH units using KCl/HCl, 
KHC8H8O4/HCl, KH2PO4/NaOH and Na2HPO4/NaOH buffers. Vis-absorption spectra of buffered 
indicator solutions were recorded on a Varian-Cary 100 Bio UV-Vis spectrophotometer.  
 
Figure Captions 
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Fig. 1 PXRD patterns for (A) SFN-Ǆ and (B) SFN-ǅ. 
 
Fig. 2. DRV spectra for the calibration samples containing fractional amounts of dye treated 
SFN polymorphs. DRV spectra of pure polymorphs are shown as SFN-Ȗ-TB (10Ȗ μ 0.0ȕ) and 
SFN-ȕ-TB (0.0Ȗ μ 1.0ȕ). Inset: Calibration plot of F(r)604nm/454nm versus fractional amounts 
SFN-Ȗ-TB; r2 = 0.99. 
 
Fig. 3. DRV spectroscopic data for the ȕ→Ȗ transformation in sulfanilamide at 1β5±0.5 ºC 
 
Fig. 4. SFN-ȕ transformed (α/αmax) versus time plot for the ȕ to Ȗ polymorphic transformation of 
SFN at 125± 0.5ºC. Inset: Linear regression analysis of the ȕ to Ȗ polymorphic transformation of 
SFN at 125±0.5 ºC. 
 
Fig. 1 PXRD patterns for (A) SFN-ȕ and (B) SFN-Ȗ. 
 
16 
5 10 15 20 25 30 35
 
 
 
Simulated
Experimental
o2theta
R
e
la
tiv
e
 
in
te
n
s
ity
 
(I/
I m
a
x
) /
 
a
rb
itr
a
ry
 
u
n
its
 
 
 
 
(A) 
17 
5 10 15 20 25 30 35
Simulated
Experimental
o2theta
R
e
la
tiv
e
 
In
te
n
s
ity
 
(I/
I m
a
x
) /
 
a
rb
itr
a
ry
 
u
n
its
 
 
(B) 
18 
 
400 450 500 550 600 650 700 750
0.0
0.2
0.4
0.6
0.8
1.0
604nm
 0.0 1.0
 0.2 0.8
 0.4 0.6
 0.6 0.4
 0.8 0.2
 1.0 0.0
Wavelength / nm
F 
(r)
454nm
 
 
 
Fig. 2. DRV spectra for the calibration samples containing fractional amounts of dye treated 
SFN polymorphs. DRV spectra of pure polymorphs are shown as SFN-Ȗ-TB (1.0Ȗ μ 0.0ȕ) and 
SFN-ȕ-TB (0.0Ȗ μ 1.0ȕ). Inset: Calibration plot of F(r)604nm/454nm versus fractional amounts 
SFN-Ȗ-TB; r2 = 0.99. 
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Fig. 3. DRV spectroscopic data for the ȕ→Ȗ transformation in sulfanilamide at 
125±0.5ºC 
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Fig. 4. SFN-ȕ transformed (α/αmax) versus time plot for the ȕ to Ȗ polymorphic 
transformation of SFN at 125±0.5 ºC. Inset: Linear regression analysis of the ȕ to Ȗ 
polymorphic transformation of SFN at 125±0.5 ºC. 
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